September 2016
Volume 57, Issue 12
Open Access
ARVO Annual Meeting Abstract  |   September 2016
Improved Ocular Surface Discomfort Index and Ocular Discomfort Index scores with topical autologous serum
Author Affiliations & Notes
  • Catherine Croghan
    Tennent Institute of Ophthalmology, Gartnavel General Hospital, Glasgow , United Kingdom
  • Deepa Anijeet
    Tennent Institute of Ophthalmology, Gartnavel General Hospital, Glasgow , United Kingdom
  • Footnotes
    Commercial Relationships   Catherine Croghan, None; Deepa Anijeet, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science September 2016, Vol.57, 4355. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Catherine Croghan, Deepa Anijeet; Improved Ocular Surface Discomfort Index and Ocular Discomfort Index scores with topical autologous serum. Invest. Ophthalmol. Vis. Sci. 2016;57(12):4355.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Autologous serum drops have previously been shown to improve clinical and laboratory indicators, with improved Schirmer’s test, reduced tear film debris, increased density of goblet and epithelial cells, and reduced apoptotic cells. The aim of this retrospective case series was to investigate the effect of autologous serum drops on frequency of lubricant application, and any change in the Ocular Surface Discomfort Index (OSDI) and the Ocular Discomfort Index (ODI) after treatment

Methods : A retrospective case series is presented of 17 patients using autologous serum topically, from 07/05/11. Autologous serum had been commenced due to graft versus host disease (n=6), Sjögren's syndrome (n=3), ocular cicatricial pemphigoid (n=2), stem cell failure (n=2), trauma to the lacrimal gland (n=1), ectodermal dysplasia (n=1), Stevens-Johnson syndrome (n=1), and neurotrophic cornea due to diabetes mellitus (n=1). There were 8 males, and 9 females. The mean age was 47(±14) years. Patients used autologous serum drops for a mean 16 (±13) months. The outcome measures were frequency of use of lubricants, OSDI and ODI scores. The outcome measures were assessed at two time points, prior to introduction of autologous serum drops and also at most recent review. The OSDI and ODI questionnaires were completed retrospectively by telephone interview. The Student’s t test was used for statistical analysis

Results : Patients instilled a mean 9 (±4) autologous serum drops per day. Prior to autologous serum, patients instilled a mean 12 (±5) drops of lubricants per day. This reduced after commencing autologus serum to a mean 3 (±4) drops of lubricant per day. The OSDI score reduced from a mean 85 to 49 after commencement of autologous serum. The mean reduction of the OSDI scare was 36 (mean±standard deviation: 36±19, 95% confidence interval ±9, p= 0.0000006). The ODI score was a mean 55 prior to autologus serum and 39 after. The mean reduction of the ODI score was 16 (mean± standard deviation: 16±8, 95% confidence interval ±4, p= 0.0000003). 3 patients discontinued use of autologous serum; the reasons identified in each case were evisceration, drops stinging on application, and the process being inconvenient

Conclusions : Autologous serum drops are a safe and effective management option. This is demonstrated by reduced frequency of lubrication, and reduced OSDI and ODI scores

This is an abstract that was submitted for the 2016 ARVO Annual Meeting, held in Seattle, Wash., May 1-5, 2016.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×